Prospective trial of oestrogen and calcium in postmenopausal women

A. Horsman, John Christopher G. Gallagher, M. Simpson, B. E C Nordin

Research output: Contribution to journalArticle

261 Citations (Scopus)

Abstract

In a prospective trial in 72 postmenopausal women to compare the effects on bone loss of no treatment, treatment with oestrogen, and treatment with cal cium the women were followed up for at least two years and examined densitometrically and morphometrically. Women in the untreated control group continued to lose bone during the two years, whereas the oestrogen-treated group lost none. Loss in the calcium-treated group was intermediate. Oestrogen appeared to inhibit endosteal bone resorption and may have stimulated subperiosteal bone apposition.

Original languageEnglish
Pages (from-to)789-792
Number of pages4
JournalBritish Medical Journal
Volume2
Issue number6090
DOIs
StatePublished - 1977
Externally publishedYes

Fingerprint

Estrogens
Calcium
Bone and Bones
Bone Resorption
Therapeutics
Control Groups

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Prospective trial of oestrogen and calcium in postmenopausal women. / Horsman, A.; Gallagher, John Christopher G.; Simpson, M.; Nordin, B. E C.

In: British Medical Journal, Vol. 2, No. 6090, 1977, p. 789-792.

Research output: Contribution to journalArticle

Horsman, A. ; Gallagher, John Christopher G. ; Simpson, M. ; Nordin, B. E C. / Prospective trial of oestrogen and calcium in postmenopausal women. In: British Medical Journal. 1977 ; Vol. 2, No. 6090. pp. 789-792.
@article{d62ceaa5e35e4438bc40c6bdec5d4974,
title = "Prospective trial of oestrogen and calcium in postmenopausal women",
abstract = "In a prospective trial in 72 postmenopausal women to compare the effects on bone loss of no treatment, treatment with oestrogen, and treatment with cal cium the women were followed up for at least two years and examined densitometrically and morphometrically. Women in the untreated control group continued to lose bone during the two years, whereas the oestrogen-treated group lost none. Loss in the calcium-treated group was intermediate. Oestrogen appeared to inhibit endosteal bone resorption and may have stimulated subperiosteal bone apposition.",
author = "A. Horsman and Gallagher, {John Christopher G.} and M. Simpson and Nordin, {B. E C}",
year = "1977",
doi = "10.1136/bmj.2.6090.789",
language = "English",
volume = "2",
pages = "789--792",
journal = "The BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "6090",

}

TY - JOUR

T1 - Prospective trial of oestrogen and calcium in postmenopausal women

AU - Horsman, A.

AU - Gallagher, John Christopher G.

AU - Simpson, M.

AU - Nordin, B. E C

PY - 1977

Y1 - 1977

N2 - In a prospective trial in 72 postmenopausal women to compare the effects on bone loss of no treatment, treatment with oestrogen, and treatment with cal cium the women were followed up for at least two years and examined densitometrically and morphometrically. Women in the untreated control group continued to lose bone during the two years, whereas the oestrogen-treated group lost none. Loss in the calcium-treated group was intermediate. Oestrogen appeared to inhibit endosteal bone resorption and may have stimulated subperiosteal bone apposition.

AB - In a prospective trial in 72 postmenopausal women to compare the effects on bone loss of no treatment, treatment with oestrogen, and treatment with cal cium the women were followed up for at least two years and examined densitometrically and morphometrically. Women in the untreated control group continued to lose bone during the two years, whereas the oestrogen-treated group lost none. Loss in the calcium-treated group was intermediate. Oestrogen appeared to inhibit endosteal bone resorption and may have stimulated subperiosteal bone apposition.

UR - http://www.scopus.com/inward/record.url?scp=0017668520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017668520&partnerID=8YFLogxK

U2 - 10.1136/bmj.2.6090.789

DO - 10.1136/bmj.2.6090.789

M3 - Article

VL - 2

SP - 789

EP - 792

JO - The BMJ

JF - The BMJ

SN - 0959-8146

IS - 6090

ER -